Venous thromboembolism is a significant cause of illness and death worldwide. Large
bodies of evidence support the heightened risk status of hospitalized medical patients, and …

Background Venous thromboembolism (VTE) represents a major public health problem in A
ustralia and worldwide, contributing to hundreds of thousands of deaths each year. Aim To …

Introduction Venous thromboembolism (VTE) carries a considerable risk of recurrence and
anticoagulants should be administered for a minimum of three months. Since little is known …

Introduction Bien qu'il ait été montré que le traitement préventif de la thrombose veineuse
réduisait la mortalité chez les patients hospitalisés, la plupart des études visant à évaluer les …

Background Despite the existence of active prophylaxis strategies for patients at risk of
venous thromboembolism (VTE), people still suffer from this disease. To establish the setting …

Background Hospital‐acquired venous thromboembolism (VTE) is a major cause of
morbidity and mortality. Aims To determine the proportion of patients with hospital‐acquired …

Introduction Venous thromboembolism (VTE) is a major health concern, with an annual
incidence of~ 1 in 1,000. The epidemiology of VTE in Saudi Arabia has not been adequately …

The degree of thromboprophylaxis in medical outpatients is low despite a substantial risk for
venous thromboembolism (VTE). This may be attributable to difficulties in assessing risk …

Objective Despite recent advances in the field of venous thromboembolism (VTE)
prophylaxis and adherence to guideline recommendations, VTE remains a serious problem …

Deep vein thrombosis (DVT) is a potentially catastrophic condition because thrombosis, left
untreated, can result in detrimental pulmonary embolism. Yet in the absence of thrombosis …